Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending December 13, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding their interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure of share transactions and does not contain financial performance data.
Material Changes
The filing details the acquisition of Ordinary Shares by four individuals (Mr. J S Heslop, Mr. R Bondy, Mr. D Learmouth, and Mr. A P Witty) on December 11, 2006. Each individual acquired 10 shares through the personal contribution element and 10 shares through the company matching element of the ShareReward Plan. The transaction price was GBP 13.53 per share.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of the specific share transactions described above.
Investor Verification Points
- Verify the total number of shares acquired by each named director (20 shares per person: 10 personal, 10 matched).
- Confirm the transaction date of December 11, 2006, and the share price of GBP 13.53.
- Note that this filing does not contain financial results; investors should refer to Form 20-F or quarterly reports for financial metrics.